1. Home
  2. RDY vs JKHY Comparison

RDY vs JKHY Comparison

Compare RDY & JKHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • JKHY
  • Stock Information
  • Founded
  • RDY 1984
  • JKHY 1976
  • Country
  • RDY India
  • JKHY United States
  • Employees
  • RDY N/A
  • JKHY N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • JKHY Retail: Computer Software & Peripheral Equipment
  • Sector
  • RDY Health Care
  • JKHY Technology
  • Exchange
  • RDY Nasdaq
  • JKHY Nasdaq
  • Market Cap
  • RDY 11.8B
  • JKHY 12.6B
  • IPO Year
  • RDY N/A
  • JKHY N/A
  • Fundamental
  • Price
  • RDY $14.12
  • JKHY $160.71
  • Analyst Decision
  • RDY Strong Buy
  • JKHY Hold
  • Analyst Count
  • RDY 2
  • JKHY 10
  • Target Price
  • RDY $16.95
  • JKHY $184.70
  • AVG Volume (30 Days)
  • RDY 962.0K
  • JKHY 841.1K
  • Earning Date
  • RDY 07-23-2025
  • JKHY 08-19-2025
  • Dividend Yield
  • RDY 0.51%
  • JKHY 1.44%
  • EPS Growth
  • RDY 2.20
  • JKHY 19.31
  • EPS
  • RDY 0.79
  • JKHY 6.24
  • Revenue
  • RDY $3,897,394,052.00
  • JKHY $2,375,288,000.00
  • Revenue This Year
  • RDY $7.33
  • JKHY $7.48
  • Revenue Next Year
  • RDY $1.96
  • JKHY $6.38
  • P/E Ratio
  • RDY $17.94
  • JKHY $25.77
  • Revenue Growth
  • RDY 15.86
  • JKHY 7.21
  • 52 Week Low
  • RDY $12.26
  • JKHY $157.80
  • 52 Week High
  • RDY $16.41
  • JKHY $196.00
  • Technical
  • Relative Strength Index (RSI)
  • RDY 45.65
  • JKHY 39.32
  • Support Level
  • RDY $14.08
  • JKHY $161.86
  • Resistance Level
  • RDY $14.32
  • JKHY $164.99
  • Average True Range (ATR)
  • RDY 0.18
  • JKHY 2.95
  • MACD
  • RDY 0.03
  • JKHY 0.56
  • Stochastic Oscillator
  • RDY 10.38
  • JKHY 28.03

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About JKHY Jack Henry & Associates Inc.

Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.

Share on Social Networks: